SYNGENE SYNVENT Trademark

Trademark Overview


On Tuesday, July 21, 2020, a trademark application was filed for SYNGENE SYNVENT with the United States Patent and Trademark Office. The USPTO has given the SYNGENE SYNVENT trademark a serial number of 90065058. The federal status of this trademark filing is REGISTERED as of Tuesday, April 5, 2022. This trademark is owned by Syngene International Limited. The SYNGENE SYNVENT trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical diagnostic testing, monitoring and reporting services; preparation of reports relating to medical matters; services for the testing of urine; pathology services for medical and diagnostic purposes

Scientific research and custom synthesis; scientific and clinical research in the field of medicine, pharmaceutical, nutraceuticals; scientific research and development; custom design and development of chemical reagents and biochemical assays; laboratory testing services for research purposes; testing of pharmaceuticals; chemical engineering; drug discovery services; pharmaceutical drug development services; pharmaceutical products development; development of pharmaceutical preparations and medicines; scientific study and research in the field of reproduction, husbandry, and general health of animal; biotechnology research for determining the neuronal survival of molecules in animal models; research and development services in the field of antibodies, antibody technology; custom design and development of chemical reagents and biochemical assays; design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customi...
syngene synvent

General Information


Serial Number90065058
Word MarkSYNGENE SYNVENT
Filing DateTuesday, July 21, 2020
Status700 - REGISTERED
Status DateTuesday, April 5, 2022
Registration Number6695032
Registration DateTuesday, April 5, 2022
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 1, 2021

Trademark Statements


Description of MarkThe mark consists of the word "SYNGENE", in a smaller font, above the right half of the word "SYNVENT", the word "SYNVENT" having the the outline of the letter "V" within a solid circle.
Goods and ServicesMedical diagnostic testing, monitoring and reporting services; preparation of reports relating to medical matters; services for the testing of urine; pathology services for medical and diagnostic purposes
Goods and ServicesScientific research and custom synthesis; scientific and clinical research in the field of medicine, pharmaceutical, nutraceuticals; scientific research and development; custom design and development of chemical reagents and biochemical assays; laboratory testing services for research purposes; testing of pharmaceuticals; chemical engineering; drug discovery services; pharmaceutical drug development services; pharmaceutical products development; development of pharmaceutical preparations and medicines; scientific study and research in the field of reproduction, husbandry, and general health of animal; biotechnology research for determining the neuronal survival of molecules in animal models; research and development services in the field of antibodies, antibody technology; custom design and development of chemical reagents and biochemical assays; design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for medical, scientific, and technological applications; toxicology services; toxicity analysis; toxicity testing for research purposes; conducting clinical trials for scientific research for others; conducting clinical trials for others in the field of pharmaceutical products; providing medical and scientific research information in the field of clinical trials; conducting early evaluations in the field of new pharmaceuticals; DNA analysis services for scientific research purposes; laboratory research in the field of gene expression; blood analysis services for scientific research purposes; analysis of human tissues for medical research; scientific services relating to the isolation and cultivation of human tissues and cells for research purposes; preparation of reports relating to scientific and technical research; analysis in the field of molecular biology; contract research services relating to molecular sciences; biological cloning services; structural and functional analysis of genomes; scientific and medical laboratory services; services of a chemical and/or biological laboratory; laboratory research services relating to pharmaceuticals; research and development and consultation related thereto in the field of antibodies, antibody technology, chemistry, bioinformatics, biomedical devices, biologics, biotechnology, biotherapeutics, biology, biochemical preparations, cell line, chemoinformatic, genetics and genetic engineering, gene expression systems, in vitro research, inhalation pharmaceuticals, molecular sciences, micro-organisms, nutrition, ophthalmic preparations, pharmacogenetics, pharmacokinetics, pharmacology, pharmaceuticals, polymer, peptide synthesis, protein, and solid state characterization; toxicokinetic analysis and toxicology services; scientific and technological services, namely, scientific research, development, analysis, testing, engineering, extraction, synthesis, purification and production in the field of antibodies, active pharmaceutical ingredients (API), biomolecules, cell bank characterization, chirality, chromosome aberration, clinical chemistry, cloning vector, cyclotides, DNA, flow cytometry, gas chromatography mass spectrometry, genes, immuno-pharmaceuticals, in vitro irritation, large molecule, liquid chromatography mass spectrometry, microbials, monomers, nanoparticles, natural products, peptides, proteins, RNA, supercritical fluid chromatography, small molecules and vaccines; none of the aforesaid services relating to gel imaging and gel analysis applications and none of the aforesaid services in the field of agriculture, horticulture and forestry

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 18, 2020
Primary Code042
First Use Anywhere DateWednesday, August 11, 2021
First Use In Commerce DateWednesday, August 11, 2021

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 18, 2020
Primary Code044
First Use Anywhere DateWednesday, August 11, 2021
First Use In Commerce DateWednesday, August 11, 2021

Trademark Owner History


Party NameSyngene International Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressKarnataka 560099
IN

Party NameSyngene International Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressKarnataka 560099
IN

Party NameSyngene International Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressKarnataka 560099
IN

Trademark Events


Event DateEvent Description
Tuesday, April 5, 2022REGISTERED-PRINCIPAL REGISTER
Friday, March 4, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, March 3, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, February 15, 2022STATEMENT OF USE PROCESSING COMPLETE
Thursday, January 27, 2022USE AMENDMENT FILED
Monday, February 14, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 27, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, July 27, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 1, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 1, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 12, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 29, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 29, 2021EXAMINER'S AMENDMENT ENTERED
Thursday, April 29, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, April 29, 2021EXAMINERS AMENDMENT E-MAILED
Thursday, April 29, 2021EXAMINERS AMENDMENT -WRITTEN
Monday, November 9, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 9, 2020NON-FINAL ACTION E-MAILED
Monday, November 9, 2020NON-FINAL ACTION WRITTEN
Wednesday, November 4, 2020ASSIGNED TO EXAMINER
Wednesday, August 19, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, August 18, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, July 29, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 29, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 29, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, July 24, 2020NEW APPLICATION ENTERED IN TRAM